Source: BioPortfolio

TPG Biotech: Avalon TPG Lead $15M Deal to Advance Metformin as Cancer Drug

Metformin has long been the firstline drug of choice for treating type 2 diabetes. While insulin may be better known its been available since the 1920s metformin was introduced in the UK in 1958 FDA approval in the U.S. occurred in 1995 and metformin is no...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Fred Cohen's photo - Managing Director of TPG Biotech

Managing Director

Fred Cohen

CEO Approval Rating

69/100

Read more